Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Celestica's exposure to AI infrastructure (servers, storage, networking) and the newly launched SD6300 give the stock a clear demand story even as management increases CAPEX to capture larger contracts. The trade: buy on a pullback to $285.11, stop at $260.00, target $340.00 over a mid-term 45 trading day horizon — positive catalyst-driven trade wi…
Maersk and Hapag-Lloyd announced they will route one of their jointly operated services through the Red Sea and the Suez Canal, with naval protection, reversing the detours around Africa that followed attacks in late 2023. The move is part of the carriers' Gemini network strategy to lower costs and strengthen schedule reliability.
KeyBanc reduced its price target on The Trade Desk (TTD) to $40 from $88 while keeping an Overweight rating, reflecting a tempered growth outlook and lower valuation multiples. The firm trimmed its 2026 and 2027 revenue forecasts and corresponding EBITDA projections. The Trade Desk’s shares trade near a 52-week low as the company navigates a CFO tr…
KeyBanc has reaffirmed an Overweight rating on Revvity Inc (NYSE: RVTY) and set a $125 price target, signaling roughly 16.7% upside from the current share price. The firm maintained its positive view even after Revvity guided fiscal 2026 organic growth of 2-3%, noting stronger end-of-year momentum and opportunities from accelerated share buybacks.
Relay Therapeutics Inc. (NASDAQ: RLAY) saw its stock climb in premarket trading after the U.S. Food and Drug Administration awarded Breakthrough Therapy designation to zovegalisib in combination with fulvestrant for a defined breast cancer population. The decision was supported by Phase 1/2 ReDiscover trial data and covers adults with PIK3CA-mutant…
Morgan Stanley says Broadcom’s recent underperformance could reverse if the company clears key questions about competitive dynamics, profitability from rack sales and overall valuation. Analyst Joseph Moore highlights concerns around TPU competition, customer-owned ASIC tooling and margins tied to Anthropic rack deployments, but judges many worries…
Sangoma is a small-cap Communications-as-a-Service provider trading at $4.99 with a market cap of roughly $158M and a sub-1.0 P/B. Recent operating dynamics point to a likely margin inflection from higher-margin trunking and platform revenue that the market is not fully pricing. This idea is a tactical long for a mid-term horizon (45 trading days) …
Bank of America has raised its fourth-quarter 2026 AUD/USD forecast to 0.73 following a recent Reserve Bank of Australia rate increase that has left Australian policy rates higher than U.S. Federal Reserve rates. The bank cited rising commodity prices and an anticipated weakening of the U.S. dollar versus Asian currencies as key supports, while fla…
Oracle's plan to raise $45-50 billion to fund AI-focused cloud expansion has pushed the stock lower but also creates a high-conviction trade: buy into the sell-off at $160 with a long-term horizon. Technicals show oversold conditions, fundamentals show a profitable software base and strong ROE, and analysts still forecast upside. The trade accepts …
Karen Clark and Company (KCC) estimates private insured losses from the January winter storm at $6.7 billion. The system brought heavy snow, sleet and freezing rain across parts of the eastern and southern United States, producing widespread power outages, hazardous travel conditions, flight disruptions and significant property damage including bur…
Exxon Mobil is trading near $138 while delivering industry-leading production and cash flow. With a market cap around $580B, EV/EBITDA near 9.2 and roughly $24B in free cash flow, the company offers a mix of yield, buybacks and operational optionality that buffers it against cyclical oil weakness. This trade idea lays out entry, stops and targets f…
Bernstein SocGen Group raised its price objective on Tyson Foods to $69 from $60 following first-quarter fiscal 2026 results that beat expectations. The firm, however, kept a Market Perform rating, citing the company’s beef business as a continuing source of uncertainty. Tyson reported adjusted EPS and revenue above forecasts, and Barclays reiterat…
Bernstein SocGen Group reaffirmed an Outperform rating and a $160.00 price target on Robinhood Markets (NASDAQ:HOOD), even as the stock has fallen sharply this year. Analysts’ targets on the shares range from $90 to $180. The firm highlighted the company’s crypto-related revenue exposure and valuation measures, while other banks reiterated bullish …
Bernstein has reiterated an Outperform rating and a $115 price target on Uber Inc. ahead of the company’s fourth-quarter 2025 results, while also noting persistent uncertainty around autonomous vehicle deployment. The firm and other analysts view the stock as discounted relative to fundamentals, even as robotaxi developments and competitive moves i…
U.S. authorities are assessing whether certain cryptocurrency platforms have been used to help Iranian state-linked actors and others evade sanctions, as blockchain firms record a surge in crypto flows connected to Iran. Estimates from multiple analytics firms point to billions of dollars in on-chain activity in recent years, with disagreement over…
Richmond Federal Reserve President Tom Barkin said the rate cuts enacted since fall 2024 have provided insurance for the labor market as the Fed works to finish the ‘last mile’ of returning inflation to its 2% goal. Barkin noted that unemployment remains low by historical measures and inflation is about one percentage point above target but is expe…
Federal Reserve Governor Stephen Miran told Fox Business Network he expects more than a percentage point of interest rate reductions this year, arguing current policy is too restrictive even though headline inflation remains above the 2% target. Miran, whose term technically ended at the close of January but who remains in office until a successor …
Guggenheim increased its price target for McDonald’s to $325 from $310 while leaving its rating at Neutral, raising 2026 EPS estimates and expanding the valuation multiple. The firm also revised same-store sales expectations for late 2025 and reported on new product tests. Other broker notes ahead of McDonald’s fourth-quarter results show a range o…
Scotiabank reduced its price target for Oracle to $220 from $260 while retaining a Sector Outperform rating, citing the company's $45-50 billion capital plan and remaining medium-term financing questions tied to the Oracle Cloud Infrastructure buildout. The bank trimmed Oracle's fiscal 2026 and 2027 EPS forecasts and flagged execution on major data…
Apple's newest window of upside is less about heavy new factories and more about software-led AI features that accelerate iPhone replacement and lift services monetization. The company prints massive free cash flow and runs a disciplined capital plan; combine that with early signs of a 23% iPhone sales surge and constructive technicals and you have…
SpaceX has acquired xAI, bringing the Grok chatbot maker together with the rocket-and-satellite company and creating a combined platform that ties artificial intelligence and space operations under a single corporate umbrella. The transaction assigns valuations of $1 trillion to SpaceX and $250 billion to xAI, and takes place as SpaceX prepares for…
GLJ Research cut its rating on Daqo New Energy (NYSE: DQ) from Buy to Sell and assigned a new price target of $18.13, reflecting a material downside from recent levels. The downgrade cites uncertainty in China’s polysilicon supply-and-demand balance and regulatory execution, while company-level metrics show a projected revenue decline and deeply ne…
Futures tied to Canada’s main stock index moved higher as gold prices stabilized after steep losses and traders prepared for a large slate of corporate results. Strength in consumer sectors supported the TSX rebound, while the energy group remained pressured by softer oil following signs of easing U.S.-Iran tensions. U.S. futures also ticked up ami…
Arbutus is a small-cap clinical-stage biotech where two near-term vectors - LNP-related litigation and follow-up imdusiran efficacy readouts - can produce outsized moves. Market capitalization sits near $844M while recent clinical data showed meaningful reductions in HBsAg. High short interest and above-average volume amplify both upside and downsi…
Stephens Research’s 2026 Best Ideas list highlights a selection of consumer-focused companies the firm expects to outperform peers next year. The brokerage emphasizes that durable brands, the ability to raise prices and idiosyncratic operational improvements - rather than broad macro trends - underpin the call. Top picks span specialty retail, cons…
